Moreover, testosterone supplementation resulted in strong AR-pathway activation in PC346C-DCC-K tumours as exemplified by increased prostate-specific antigen production, AR nuclear localisation, AR target gene expression and tumour cell proliferation (Supplementary Fig. 2). This evidence concerns the gene AR and neoplasm.